Cargando…
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
BACKGROUND AND AIM: Portal vein thrombosis (PVT) is a common complication of cirrhosis. The exact pathophysiology remains largely unknown, and treatment with anticoagulants does not lead to recanalization of the portal vein in all patients. A better insight into the structure and composition of port...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300169/ https://www.ncbi.nlm.nih.gov/pubmed/34559897 http://dx.doi.org/10.1002/hep.32169 |
_version_ | 1784751150213365760 |
---|---|
author | Driever, Ellen G. von Meijenfeldt, Fien A. Adelmeijer, Jelle de Haas, Robbert J. van den Heuvel, Marius C. Nagasami, Chandrasekaran Weisel, John W. Fondevila, Constantino Porte, Robert J. Blasi, Anabel Heaton, Nigel Gregory, Stephen Kane, Pauline Bernal, William Zen, Yoh Lisman, Ton |
author_facet | Driever, Ellen G. von Meijenfeldt, Fien A. Adelmeijer, Jelle de Haas, Robbert J. van den Heuvel, Marius C. Nagasami, Chandrasekaran Weisel, John W. Fondevila, Constantino Porte, Robert J. Blasi, Anabel Heaton, Nigel Gregory, Stephen Kane, Pauline Bernal, William Zen, Yoh Lisman, Ton |
author_sort | Driever, Ellen G. |
collection | PubMed |
description | BACKGROUND AND AIM: Portal vein thrombosis (PVT) is a common complication of cirrhosis. The exact pathophysiology remains largely unknown, and treatment with anticoagulants does not lead to recanalization of the portal vein in all patients. A better insight into the structure and composition of portal vein thrombi may assist in developing strategies for the prevention and treatment of PVT. APPROACH AND RESULTS: Sixteen prospectively and 63 retrospectively collected nonmalignant portal vein thrombi from patients with cirrhosis who underwent liver transplantation were included. Histology, immunohistochemistry, and scanning electron microscopy were used to assess structure and composition of the thrombi. Most recent CT scans were reanalyzed for thrombus characteristics. Clinical characteristics were related to histological and radiological findings. All samples showed a thickened, fibrotic tunica intima. Fibrin‐rich thrombi were present on top of the fibrotic intima in 9/16 prospective cases and in 21/63 retrospective cases. A minority of the fibrotic areas stained focally positive for fibrin/fibrinogen (16% of cases), von Willebrand factor (VWF; 10%), and CD61 (platelets, 21%), while most of the fibrin‐rich areas stained positive for those markers (fibrin/fibrinogen, 100%; VWF, 77%; CD61, 100%). No associations were found between clinical characteristics including estimated thrombus age and use of anticoagulants and presence of fibrin‐rich thrombi. CONCLUSION: We demonstrate that PVT in patients with cirrhosis consists of intimal fibrosis with an additional fibrin‐rich thrombus in only one‐third of cases. We hypothesize that our observations may explain why not all portal vein thrombi in patients with cirrhosis recanalize by anticoagulant therapy. |
format | Online Article Text |
id | pubmed-9300169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93001692022-07-21 Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus Driever, Ellen G. von Meijenfeldt, Fien A. Adelmeijer, Jelle de Haas, Robbert J. van den Heuvel, Marius C. Nagasami, Chandrasekaran Weisel, John W. Fondevila, Constantino Porte, Robert J. Blasi, Anabel Heaton, Nigel Gregory, Stephen Kane, Pauline Bernal, William Zen, Yoh Lisman, Ton Hepatology Original Articles BACKGROUND AND AIM: Portal vein thrombosis (PVT) is a common complication of cirrhosis. The exact pathophysiology remains largely unknown, and treatment with anticoagulants does not lead to recanalization of the portal vein in all patients. A better insight into the structure and composition of portal vein thrombi may assist in developing strategies for the prevention and treatment of PVT. APPROACH AND RESULTS: Sixteen prospectively and 63 retrospectively collected nonmalignant portal vein thrombi from patients with cirrhosis who underwent liver transplantation were included. Histology, immunohistochemistry, and scanning electron microscopy were used to assess structure and composition of the thrombi. Most recent CT scans were reanalyzed for thrombus characteristics. Clinical characteristics were related to histological and radiological findings. All samples showed a thickened, fibrotic tunica intima. Fibrin‐rich thrombi were present on top of the fibrotic intima in 9/16 prospective cases and in 21/63 retrospective cases. A minority of the fibrotic areas stained focally positive for fibrin/fibrinogen (16% of cases), von Willebrand factor (VWF; 10%), and CD61 (platelets, 21%), while most of the fibrin‐rich areas stained positive for those markers (fibrin/fibrinogen, 100%; VWF, 77%; CD61, 100%). No associations were found between clinical characteristics including estimated thrombus age and use of anticoagulants and presence of fibrin‐rich thrombi. CONCLUSION: We demonstrate that PVT in patients with cirrhosis consists of intimal fibrosis with an additional fibrin‐rich thrombus in only one‐third of cases. We hypothesize that our observations may explain why not all portal vein thrombi in patients with cirrhosis recanalize by anticoagulant therapy. John Wiley and Sons Inc. 2021-12-05 2022-04 /pmc/articles/PMC9300169/ /pubmed/34559897 http://dx.doi.org/10.1002/hep.32169 Text en © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Driever, Ellen G. von Meijenfeldt, Fien A. Adelmeijer, Jelle de Haas, Robbert J. van den Heuvel, Marius C. Nagasami, Chandrasekaran Weisel, John W. Fondevila, Constantino Porte, Robert J. Blasi, Anabel Heaton, Nigel Gregory, Stephen Kane, Pauline Bernal, William Zen, Yoh Lisman, Ton Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus |
title | Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus |
title_full | Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus |
title_fullStr | Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus |
title_full_unstemmed | Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus |
title_short | Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus |
title_sort | nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300169/ https://www.ncbi.nlm.nih.gov/pubmed/34559897 http://dx.doi.org/10.1002/hep.32169 |
work_keys_str_mv | AT drieverelleng nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT vonmeijenfeldtfiena nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT adelmeijerjelle nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT dehaasrobbertj nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT vandenheuvelmariusc nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT nagasamichandrasekaran nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT weiseljohnw nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT fondevilaconstantino nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT porterobertj nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT blasianabel nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT heatonnigel nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT gregorystephen nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT kanepauline nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT bernalwilliam nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT zenyoh nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus AT lismanton nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus |